Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27684210)
Watch
English
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
(English)
0 references
main subject
organic chemistry
0 references
drug discovery
0 references
author
Jean-Christophe Harmange
series ordinal
8
0 references
author name string
Victor S Gehling
series ordinal
1
0 references
Michael C Hewitt
series ordinal
2
0 references
Rishi G Vaswani
series ordinal
3
0 references
Yves Leblanc
series ordinal
4
0 references
Alexandre Côté
series ordinal
5
0 references
Christopher G Nasveschuk
series ordinal
6
0 references
Alexander M Taylor
series ordinal
7
0 references
James E Audia
series ordinal
9
0 references
Eneida Pardo
series ordinal
10
0 references
Shivangi Joshi
series ordinal
11
0 references
Peter Sandy
series ordinal
12
0 references
Jennifer A Mertz
series ordinal
13
0 references
Robert J Sims
series ordinal
14
0 references
Louise Bergeron
series ordinal
15
0 references
Barbara M Bryant
series ordinal
16
0 references
Steve Bellon
series ordinal
17
0 references
Florence Poy
series ordinal
18
0 references
Hariharan Jayaram
series ordinal
19
0 references
Ravichandran Sankaranarayanan
series ordinal
20
0 references
Sreegouri Yellapantula
series ordinal
21
0 references
Nandana Bangalore Srinivasamurthy
series ordinal
22
0 references
Swarnakumari Birudukota
series ordinal
23
0 references
Brian K Albrecht
series ordinal
24
0 references
language of work or name
English
1 reference
based on heuristic
litr
publication date
12 September 2013
0 references
published in
ACS Medicinal Chemistry Letters
1 reference
stated in
Crossref
volume
4
0 references
issue
9
0 references
page(s)
835-40
0 references
cites work
Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Discovery and characterization of small molecule inhibitors of the BET family bromodomains
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Suppression of inflammation by a synthetic histone mimic
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Selective inhibition of BET bromodomains
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
20 March 2017
Targeting MYC dependence in cancer by inhibiting BET bromodomains
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
7 April 2017
Ligand efficiency indices for effective drug discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
Ligand efficiency and fragment-based drug discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
The Myc oncoprotein as a therapeutic target for human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
N-tert-Butanesulfinyl Imines: Versatile Intermediates for the Asymmetric Synthesis of Amines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
29 September 2017
An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4027525
retrieved
27 November 2018
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24900758
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1021/ML4001485
0 references
PMC publication ID
4027525
0 references
PubMed publication ID
24900758
0 references
ResearchGate publication ID
262927146
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit